Youngevity International, Inc. announced that it has received notice from the Nasdaq Hearings Panel that its company’s securities will be delisted from The Nasdaq Stock Market LLC.
This determination was made based upon the company’s non-compliance with the filing requirements set forth in Nasdaq Listing Rule 5250(c)(1) for failing to file its Form 10-K for the year ending December 31, 2019, and Forms 10-Q for the period ending March 31, 2020 and June 30, 2020.
Trading suspension of the company’s securities will be effective November 20, 2020. Youngevity expects its common stock and Series D preferred stock to be eligible to trade on the OTC Markets system on the same day. Both Series D and OTC Markets stocks will likely continue to be traded under its current trading symbols YGYI and YGIP.
“We are in the process of preparing a shareholder communication letter which will provide an update on recent progress that has been made at the company including business highlights, and our plan to become current in our financial reporting and relist on Nasdaq or another national securities exchange,” says Youngevity International, Inc. Chief Executive Officer Steve Wallach.